Cypherpunk Technologies Inc. Common Stock

Day range

$2.66 – $2.90

Open

$2.77

Prev close

$2.82

Volume

7.4M

Market cap

$303.9M

Shares out

107.76M

P/E

—

P/S

—

P/B

2.18

P/FCF

—

ROE

-0.6%

ROA

-0.6%

Debt/Equity

0.00

Div yield

0.00%

As of Oct 23, 2026

• Director appointmentSep 22, 2026

  “On September 22, 2026, the Board of Directors (the "Board") of Cypherpunk Technologies Inc. (the "Company") appointed Amanda Fabiano to serve as a Class III director on the Board, effective immediately.”

• Listing compliance regainedSep 2, 2026

  On September 2, 2026, the Company received a letter from Nasdaq notifying the Company that it had regained compliance with Nasdaq Listing Rule 55520(a)(2), and the matter is now closed.

• Acquisition agreementAug 18, 2026

  On August 17, 2026 (the "Closing Date"), Cypherpunk Technologies Inc., a Delaware corporation (the "Company") entered into an Asset Purchase Agreement (the "APA") with Moria Mining, LLC...Pursuant to the APA, the Buyer agreed (i) to purchase and acquire from the Seller certain assets and rights (collectively, the "Purchased Assets")...at an aggregate purchase price of $33,333,333, payable in the form of a pre-funded warrant to purchase 43,290,042 shares of common stock.

• Clinical trial resultsAug 12, 2026

  Also on August 12, 2026, Leap Therapeutics, Inc., the biotechnology subsidiary of the Company, announced the publication of results from the randomized Phase 2 DeFianCe study of sirexatamab (DKN-01), an anti-DKK1 monoclonal antibody, in Clinical Cancer Research.

• Listing deficiency noticeJul 21, 2026

  On July 20, 2026, Cypherpunk Technologies Inc. (the "Company") received a notification letter (the "Closing Bid Price Deficiency Letter") from the Listing Qualifications staff of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that, for the last 30 consecutive business days, the closing bid price for the Company's common stock has been below the minimum $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2). The Company has 180 days, or until January 19, 2027, to regain compliance with Rule 5550(a)(2) by maintaining a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days.

Days to cover

1.0

Short interest

13.45M

Avg volume

22.28M

As of Sep 30, 2026 · reported to FINRA twice monthly.

• 2 Cryptocurrencies Poised to Surge 100% in the Coming Years That Savvy Investors Are Already Buying
  positiveThe Motley Fool· Oct 10, 2026
• 2 Cryptocurrencies Worth Buying Over AI Stocks Right Now
  negativeThe Motley Fool· Sep 21, 2026